Ceftriaxone 500 mg Injection, marketed as Triazo 500, is a potent third-generation cephalosporin antibiotic effective against severe bacterial infections. Administered intravenously or intramuscularly, it disrupts bacterial cell wall synthesis, leading to bacterial death. Triazo 500 offers broad-spectrum coverage against Gram-positive and Gram-negative bacteria, crucial for treating pneumonia, meningitis, and urinary tract infections under medical supervision.Available in PCD Franchise for injectable range and third party manufacturing.